These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15581530)

  • 1. Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001.
    McCabe SE; Teter CJ; Boyd CJ; Guthrie SK
    J Adolesc Health; 2004 Dec; 35(6):501-4. PubMed ID: 15581530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Illicit methylphenidate use in an undergraduate student sample: prevalence and risk factors.
    Teter CJ; McCabe SE; Boyd CJ; Guthrie SK
    Pharmacotherapy; 2003 May; 23(5):609-17. PubMed ID: 12741435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate: abuse and addiction.
    Prescrire Int; 2012 Oct; 21(131):241. PubMed ID: 23189380
    [No Abstract]   [Full Text] [Related]  

  • 4. Stimulant use linked to sudden death in children without heart problems.
    Kuehn BM
    JAMA; 2009 Aug; 302(6):613-4. PubMed ID: 19671894
    [No Abstract]   [Full Text] [Related]  

  • 5. Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences.
    Bogle KE; Smith BH
    Curr Drug Abuse Rev; 2009 May; 2(2):157-76. PubMed ID: 19630746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate transdermal system.
    Mays DA; Findling R
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223. PubMed ID: 16292112
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular effects of methylphenidate.
    Daniels SR
    J Pediatr; 2009 Jul; 155(1):A3. PubMed ID: 19559283
    [No Abstract]   [Full Text] [Related]  

  • 8. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Killeen MR
    J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478
    [No Abstract]   [Full Text] [Related]  

  • 9. Is There an Effect of Methylphenidate on Thrombocytopenia?
    Ercan ES; Inci SB; Ipci M
    J Clin Psychopharmacol; 2017 Jun; 37(3):374. PubMed ID: 28301399
    [No Abstract]   [Full Text] [Related]  

  • 10. Quillivant XR--an extended release oral suspension of methylphenidate.
    Med Lett Drugs Ther; 2013 Feb; 55(1409):10-1. PubMed ID: 23381227
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
    Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
    Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylphenidate-induced erections in a prepubertal child.
    Kelly BD; Lundon DJ; McGuinness D; Brady CM
    J Pediatr Urol; 2013 Feb; 9(1):e1-2. PubMed ID: 22552161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excessive masturbation and hypersexual behavior associated with methylphenidate.
    Bilgiç A; Gürkan K; Türkoğlu S
    J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):789-90. PubMed ID: 17581441
    [No Abstract]   [Full Text] [Related]  

  • 14. Illicit use of prescribed stimulant medication among college students.
    Hall KM; Irwin MM; Bowman KA; Frankenberger W; Jewett DC
    J Am Coll Health; 2005; 53(4):167-74. PubMed ID: 15663065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OROS-Methylphenidate-Induced Raynaud's Phenomenon: A Dose-Related Side Effect.
    Bayram Ö; Hergüner S
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):521-2. PubMed ID: 26222712
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversible ischaemic neurological deficit associated with short-term methylphenidate medication.
    Leonhard C; Reif A; Beck M; Jacob C; Lesch KP
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):129-30. PubMed ID: 16004621
    [No Abstract]   [Full Text] [Related]  

  • 17. Aptensio XR--another long-acting methylphenidate.
    Med Lett Drugs Ther; 2015 Jul; 57(1473):101-3. PubMed ID: 26204039
    [No Abstract]   [Full Text] [Related]  

  • 18. Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder.
    McGough JJ; McBurnett K; Bukstein O; Wilens TE; Greenhill L; Lerner M; Stein M
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):351-6. PubMed ID: 16768642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate and chromosome damage.
    Jacobson-Kram D; Mattison D; Shelby M; Slikker W; Tice R; Witt K
    Cancer Lett; 2008 Feb; 260(1-2):216-8. PubMed ID: 18055105
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemical leukoderma after the application of a transdermal methylphenidate patch.
    Ghasri P; Gattu S; Saedi N; Ganesan AK
    J Am Acad Dermatol; 2012 Jun; 66(6):e237-8. PubMed ID: 22583724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.